Antimetabolites.- DNA-intercalators - the anthracyclines.- Topoisomerase inhibitors.- Tubulin interacting agents.- Vaccination therapies in solid tumors.- Oral anticancer agents.- Anti-angiogenesis agents.- Signal transduction inhibitors.- Endocrine therapy of breast cancer.

This topical volume provides an overview of clinically relevant data on anticancer agents. It is not only intended medical doctors working with cancer patients, and for medical researchers and students. The different classes of anticancer drugs are described by international authorities on the various topics. Apart from new targets for anticancer agents, attention is also focused on improving efficacy and tolerability of existing compounds.